These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36239422)

  • 1. Investigation of the pharmacokinetic properties of synthetic heparan sulfate oligosaccharides.
    Arnold K; Wang Z; Lucas A; Zamboni W; Xu Y; Liu J
    Glycobiology; 2023 Mar; 33(2):104-114. PubMed ID: 36239422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.
    Wu J; Wei J; Chopra P; Boons GJ; Lin C; Zaia J
    Anal Chem; 2019 Sep; 91(18):11738-11746. PubMed ID: 31423779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.
    Naimy H; Leymarie N; Zaia J
    Biochemistry; 2010 May; 49(17):3743-52. PubMed ID: 20345121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 3-
    Wang Z; Arnold K; Dhurandahare VM; Xu Y; Pagadala V; Labra E; Jeske W; Fareed J; Gearing M; Liu J
    Anal Chem; 2022 Feb; 94(6):2950-2957. PubMed ID: 35107975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.
    Huang R; Liu J; Sharp JS
    Anal Chem; 2013 Jun; 85(12):5787-95. PubMed ID: 23659663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.
    Kuberan B; Lech M; Zhang L; Wu ZL; Beeler DL; Rosenberg RD
    J Am Chem Soc; 2002 Jul; 124(29):8707-18. PubMed ID: 12121115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoenzymatic Synthesis of Homogeneous Heparan Sulfate and Chondroitin Sulfate Chimeras.
    Stancanelli E; Liu W; Wander R; Li J; Wang Z; Arnold K; Su G; Kanack A; Pham TQ; Pagadala V; Padmanabhan A; Xu Y; Liu J
    ACS Chem Biol; 2022 May; 17(5):1207-1214. PubMed ID: 35420777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of partial de-O-sulfation of heparin oligosaccharide library.
    Lin J; Zheng L; Liang Q; Jiang L; Wei Z
    Carbohydr Res; 2021 Jan; 499():108226. PubMed ID: 33401230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate.
    Xu D; Arnold K; Liu J
    Curr Opin Struct Biol; 2018 Jun; 50():155-161. PubMed ID: 29684759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic anticoagulant heparan sulfate attenuates liver ischemia reperfusion injury.
    Arnold K; Xu Y; Liao YE; Cooley BC; Pawlinski R; Liu J
    Sci Rep; 2020 Oct; 10(1):17187. PubMed ID: 33057098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.
    Staples GO; Shi X; Zaia J
    J Biol Chem; 2010 Jun; 285(24):18336-43. PubMed ID: 20363743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase.
    Parthasarathy N; Goldberg IJ; Sivaram P; Mulloy B; Flory DM; Wagner WD
    J Biol Chem; 1994 Sep; 269(35):22391-6. PubMed ID: 8071367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.
    Cole CL; Hansen SU; Baráth M; Rushton G; Gardiner JM; Avizienyte E; Jayson GC
    PLoS One; 2010 Jul; 5(7):e11644. PubMed ID: 20657775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.
    Huang R; Zong C; Venot A; Chiu Y; Zhou D; Boons GJ; Sharp JS
    Anal Chem; 2016 May; 88(10):5299-307. PubMed ID: 27087275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous-Flow Accelerated Sulfation of Heparan Sulfate Intermediates.
    Anand S; Mardhekar S; Raigawali R; Mohanta N; Jain P; D Shanthamurthy C; Gnanaprakasam B; Kikkeri R
    Org Lett; 2020 May; 22(9):3402-3406. PubMed ID: 32310663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfation Code and Conformational Plasticity of l-Iduronic Acid Homo-Oligosaccharides Mimic the Biological Functions of Heparan Sulfate.
    Shanthamurthy CD; Gimeno A; Leviatan Ben-Arye S; Kumar NV; Jain P; Padler-Karavani V; Jiménez-Barbero J; Kikkeri R
    ACS Chem Biol; 2021 Nov; 16(11):2481-2489. PubMed ID: 34586794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic design of heparan sulfate oligosaccharides.
    Liu R; Xu Y; Chen M; Weïwer M; Zhou X; Bridges AS; DeAngelis PL; Zhang Q; Linhardt RJ; Liu J
    J Biol Chem; 2010 Oct; 285(44):34240-9. PubMed ID: 20729556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.
    Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J
    PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-
    Vidaurre MDPH; Osborn BK; Lowak KD; McDonald MM; Wang YW; Pa V; Richter JR; Xu Y; Arnold K; Liu J; Cardenas JC
    Front Immunol; 2023; 14():1158457. PubMed ID: 37122735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.